Sun Pharmaceutical Industries Inc. (Sun Pharma), the fourth largest specialty generic pharmaceutical company globally, is ...

Trump plans to lower US drug prices by 30-80%, impacting Indian generic drugmakers and multinational companies.

The biosimilars business accounted for 58% of Biocon's overall revenue in FY25. Biocon Biologics had said it would likely ...

Dr. Reddy's stock is up on encouraging fiscal fourth-quarter 2025 results, wherein both earnings and revenues beat estimates, ...

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q1 CY2025 results exceeding the market’s revenue ...

Applied to medicines, price controls would translate into shortages and slow, or non-existent, introduction of new, ...

In an era where 67% of guests say they want relevant product or service recommendations, and 61% want brands to recognize ...

Enrollment underway in CHAPTER-3, a pivotal Phase 3 study of deucrictibant for prophylaxis of HAE attacks; topline data expected in 2H2026 Attack dataset continues to accumulate in RAPIDe-3, a pivotal ...

Ooops... Something went wrong while loading this page.

WisdomAI, a new force in enterprise AI, has officially emerged from stealth with $23 million in funding, led by Coatue ...

As of March 31, 2025, cash, cash equivalents and short-term investments totaled $87.3 million, compared to $100.1 million as of December 31, 2024. Cash flow from operations during the quarter was ...

Apple is developing an AI-powered battery-management feature for iOS 19 that learns individual usage patterns to optimise ...